New Data on Myeloma Drug Candidates to Be Presented by PharmaMar at Oncology Meeting
Spain-based PharmaMar announced the company will present data from…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Phase 3 Study of Stem Cell Transplantation in Multiple Myeloma Patients Showing Early Benefits
Results from an ongoing clinical trial supports the use…
Ongoing Phase 3 Study Finds Daratumumab Improves Survival in Advanced Multiple Myeloma Patients
Genmab has announced positive results from its Phase 3…
Stem Cell Transplantation to Treat Myeloma Patients Highlighted in Studies
Ajai Chari, MD, director of clinical research in the Multiple…
Leisure-Time Physical Activity Associated with Lower Cancer Risk, Including Myeloma
Leisure-time physical activity is associated with a lower risk…
Selinexor Shows Promising Clinical Results in Advanced Solid Tumors, Paving Way for Future Myeloma Trials
Newton, Massachusetts-based Karyopharm Therapeutics has published the results from its…
